Rachel Tanner

11.9k total citations
51 papers, 959 citations indexed

About

Rachel Tanner is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Rachel Tanner has authored 51 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 30 papers in Immunology and 22 papers in Epidemiology. Recurrent topics in Rachel Tanner's work include Tuberculosis Research and Epidemiology (35 papers), Immune responses and vaccinations (19 papers) and Mycobacterium research and diagnosis (19 papers). Rachel Tanner is often cited by papers focused on Tuberculosis Research and Epidemiology (35 papers), Immune responses and vaccinations (19 papers) and Mycobacterium research and diagnosis (19 papers). Rachel Tanner collaborates with scholars based in United Kingdom, South Africa and United States. Rachel Tanner's co-authors include Helen McShane, Helen A. Fletcher, Matthew K. O’Shea, Bernardo Villarreal‐Ramos, H. Martin Vordermeier, Stephanie A. Harris, Iman Satti, Michael J. Brennan, Elena Stylianou and Joel N. Meyer and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Rachel Tanner

44 papers receiving 940 citations

Peers

Countries citing papers authored by Rachel Tanner

Since Specialization

Citations

This map shows the geographic impact of Rachel Tanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Tanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Tanner more than expected).

Fields of papers citing papers by Rachel Tanner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Tanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Tanner. The network helps show where Rachel Tanner may publish in the future.

Co-authorship network of co-authors of Rachel Tanner

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Tanner. A scholar is included among the top collaborators of Rachel Tanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Tanner. Rachel Tanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Workshop report: One Health challenges and knowledge gaps in the control of intracellular infections with a focus on tuberculosis and leishmaniasis 2025 ·Vaccine ·Michele A. Miller, María Adelaida Gómez, Rachel Tanner, Samantha Vermaak, Bernardo Villarreal‐Ramos, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG 2025 ·Nature Communications ·Julia L. Marshall, Iman Satti, (unknown), Stephanie A. Harris, Hazel Morrison, (unknown), Marco Polo Peralta Álvarez, Shuailin Li, Raquel Lopez Ramon, (unknown), (unknown), Fernando Ramos Lopez, Celia Mitton, Ingrid Cabrera Puig, (unknown), Rachel Tanner, Timothy Hinks, (unknown), Helen McShane	1
3	Functional and phenotypic characterization of peripheral blood mononuclear cells from tuberculosis patients in Southern Thailand 2025 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rachel Tanner, Nawamin Pinpathomrat	0
4	MetE: a promising protective antigen for tuberculosis vaccine development 2025 ·Frontiers in Immunology ·Salem Salman Almujri, Elena Stylianou, Annalisa Nicastri, Iman Satti, (unknown), Shuailin Li, (unknown), Marco Polo Peralta Álvarez, Rachel Tanner, Paulo J. G. Bettencourt, Nicola Ternette, Helen McShane	0
5	Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route 2024 ·Vaccine ·Marco Polo Peralta Álvarez, (unknown), Andrew White, Stephanie A. Harris, Iman Satti, Shuailin Li, (unknown), Laura Sibley, Charlotte Sarfas, Mike Dennis, (unknown), Sally Sharpe, Helen McShane, Rachel Tanner	1
6	Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients 2024 ·Tuberculosis ·(unknown), (unknown), (unknown), Iman Satti, Stephanie A. Harris, Hazel Morrison, (unknown), Helen McShane, Rachel Tanner, Nawamin Pinpathomrat	1
7	MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates 2024 ·npj Vaccines ·Marco Polo Peralta Álvarez, (unknown), Andrew White, (unknown), Laura Sibley, Charlotte Sarfas, (unknown), Mike Dennis, (unknown), Stephanie A. Harris, Shuailin Li, Eugenia Puentes, Nacho Aguiló, Carlos Martı́n, (unknown), Helen McShane, Rachel Tanner	1
8	Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains 2024 ·Tuberculosis ·(unknown), Sam Willcocks, Andrea Zelmer, Rajko Reljić, Rachel Tanner, Helen A. Fletcher	4
9	Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model 2022 ·Journal of Neuroinflammation ·Tianrong Yeo, (unknown), Marcus Augusto‐Oliveira, Megan Sealey, Timothy D. W. Claridge, Rachel Tanner, David Leppert, Jacqueline Palace, Jens Kühle, Fay Probert, Daniel C. Anthony	0
10	High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation 2021 ·Scientific Reports ·Laura Sibley, Andrew White, Karen E. Gooch, (unknown), Rachel Tanner, (unknown), (unknown), Fergus Gleeson, Anthony McIntyre, Randall J. Basaraba, Simon Clark, Graham Hall, (unknown), Emma Rayner, Helen McShane, Ann Williams, Mike Dennis, Philip D. Marsh, Sally Sharpe	6
11	Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease 2021 ·Tuberculosis ·Julie G. Burel, Akul Singhania, (unknown), Julius Müller, Rachel Tanner, Eneida Abreu Parizotto, Martin Dedicoat, Tom Fletcher, James Dunbar, Adam F. Cunningham, Cecilia S. Lindestam Arlehamn, Donald G. Catanzaro, Antonino Catanzaro, Timothy C. Rodwell, Helen McShane, Matthew K. O’Shea, Bjoern Peters	14
12	Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells 2020 ·Scientific Reports ·(unknown), (unknown), (unknown), Lisa Stockdale, Rachel Tanner, Sam Willcocks, Rajko Reljić, Helen A. Fletcher, Andrea Zelmer	14
13	Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection 2020 ·Frontiers in Immunology ·Rachel Tanner, Iman Satti, Stephanie A. Harris, Matthew K. O’Shea, Deniz Cizmeci, Daniel O’Connor, Agnieszka Chomka, Magali Matsumiya, (unknown), Angela M. Minassian, Joel N. Meyer, Helen A. Fletcher, Helen McShane	21
14	A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development 2017 ·Tuberculosis ·Ilaria Pepponi, Bhagwati Khatri, Rachel Tanner, Bernardo Villarreal‐Ramos, Martin Vordermeier, Helen McShane	11
15	A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis 2016 ·BMC Infectious Diseases ·Andrea Zelmer, Rachel Tanner, Elena Stylianou, Timon Damelang, Sheldon L. Morris, Angelo Izzo, Ann Williams, Sally Sharpe, Ilaria Pepponi, Barry Walker, David A. Hokey, Helen McShane, Michael J. Brennan, Helen A. Fletcher	26
16	In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy 2016 ·Vaccine ·Rachel Tanner, Matthew K. O’Shea, Helen A. Fletcher, Helen McShane	52
17	Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction 2016 ·The Journal of Infectious Diseases ·Tingting Chen, Caroline Blanc, (unknown), Rafael Prados‐Rosales, Ana Camila Oliveira Souza, Ryung S. Kim, Aharona Glatman‐Freedman, Maju Joe, Yu Bai, Todd L. Lowary, Rachel Tanner, Michael J. Brennan, Helen A. Fletcher, Helen McShane, Arturo Casadevall, Jacqueline M. Achkar	108
18	Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A 2014 ·BMC Infectious Diseases ·Rachel Tanner, Kristina Kakalacheva, (unknown), Ansar A. Pathan, R. Chalk, Clare R. Sander, Thomas J. Scriba, Michèle Tameris, Tony Hawkridge, Hassan Mahomed, (unknown), Willem A. Hanekom, Anna M. Checkley, Helen McShane, Helen A. Fletcher	13
19	Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb) 2013 ·Tuberculosis ·Leanne Marsay, Magali Matsumiya, Rachel Tanner, Hazel Poyntz, Kristin Griffiths, Elena Stylianou, Philip D. Marsh, Ann Williams, (unknown), Helen A. Fletcher, Helen McShane	38
20	Human standing and walking: comparison of the effects of stimulation of the vestibular system 2006 ·Experimental Brain Research ·J. F. Iles, (unknown), Rachel Tanner, (unknown)	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact